» Articles » PMID: 1415528

Dexamethasone Acts Locally to Inhibit Longitudinal Bone Growth in Rabbits

Overview
Journal Am J Physiol
Specialty Physiology
Date 1992 Sep 11
PMID 1415528
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Excess glucocorticoid is a potent inhibitor of epiphysial growth. Several mechanisms have been suggested to explain this growth inhibition, including both direct local effects of glucocorticoid on the epiphysial growth plate and indirect systemic effects. Previous studies do not distinguish which of these proposed mechanisms is actually responsible for the growth suppression in vivo. To resolve this controversy, we developed a method for delivering glucocorticoid directly into the rabbit epiphysial growth plate and for accurately measuring the resulting epiphysial growth rate. Five-week-old male rabbits received a local infusion of dexamethasone phosphate (80 ng/microliters, 1 microliters/h) into one proximal tibial growth plate and an infusion of vehicle into the contralateral growth plate. Growth rate was determined by inserting metal pins into the bone immediately adjacent to the growth plate and measuring the change in distance between pins on serial radiographs. This method permitted growth rates to be measured over intervals as short as 3 days, with an error of approximately 5%. Local dexamethasone administration decreased proximal tibial growth rate by 77% compared with the contralateral vehicle-treated tibia (P less than 0.0001). We conclude that excess glucocorticoid causes a rapid potent inhibition of growth by a direct local action on the growth plate.

Citing Articles

Astragalus Extract Mixture HT042 Alleviates Dexamethasone-Induced Bone Growth Retardation in Rat Metatarsal Bones.

Baek C, Lee J, Lee D, Kim H Nutrients. 2024; 16(14).

PMID: 39064775 PMC: 11279921. DOI: 10.3390/nu16142333.


The long-term (five years) effects of prednisone therapy in children with frequently relapsing nephrotic syndrome: A controlled study of anthropometric parameters and metabolic abnormalities.

Soliman A, Hamed N, De Sanctis V, Elbaba M, Alyafei F, Alaaraj N Acta Biomed. 2022; 93(5):e2022303.

PMID: 36300219 PMC: 9686183. DOI: 10.23750/abm.v93i5.13459.


Humanin is a novel regulator of Hedgehog signaling and prevents glucocorticoid-induced bone growth impairment.

Zaman F, Zhao Y, Celvin B, Mehta H, Wan J, Chrysis D FASEB J. 2019; 33(4):4962-4974.

PMID: 30657335 PMC: 6988867. DOI: 10.1096/fj.201801741R.


Effects of exogenous growth hormone administration on dexamethasone-induced growth impairment in adolescent male rats.

Kim M, Oh J, Kim H, Leem K Exp Ther Med. 2017; 14(4):3455-3462.

PMID: 29042933 PMC: 5639423. DOI: 10.3892/etm.2017.5017.


Transforming Growth Factor Beta is regulated by a Glucocorticoid-Dependent Mechanism in Denervation Mouse Bone.

Li Y, Jie L, Tian A, Zhong S, Tian M, Zhong Y Sci Rep. 2017; 7(1):9925.

PMID: 28855536 PMC: 5577242. DOI: 10.1038/s41598-017-09793-y.